Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocarditis | 22 | 2024 | 766 | 6.990 |
Why?
|
Anthracyclines | 12 | 2023 | 282 | 2.780 |
Why?
|
Magnetic Resonance Imaging, Cine | 22 | 2021 | 1044 | 2.560 |
Why?
|
Myocardium | 20 | 2024 | 4690 | 1.910 |
Why?
|
Ventricular Remodeling | 15 | 2024 | 1256 | 1.880 |
Why?
|
Neoplasms | 41 | 2024 | 22030 | 1.870 |
Why?
|
Heart Failure | 25 | 2024 | 11594 | 1.710 |
Why?
|
Cardiomyopathies | 11 | 2023 | 1944 | 1.700 |
Why?
|
Ventricular Function, Left | 26 | 2024 | 3858 | 1.680 |
Why?
|
Cardiovascular Diseases | 26 | 2023 | 15396 | 1.660 |
Why?
|
Heart Diseases | 10 | 2023 | 2782 | 1.590 |
Why?
|
Death, Sudden, Cardiac | 8 | 2020 | 1554 | 1.550 |
Why?
|
HIV | 7 | 2020 | 1581 | 1.520 |
Why?
|
HIV Infections | 22 | 2023 | 17275 | 1.450 |
Why?
|
Heart Atria | 10 | 2017 | 1344 | 1.390 |
Why?
|
Stroke Volume | 29 | 2024 | 5460 | 1.380 |
Why?
|
Ventricular Dysfunction, Left | 15 | 2022 | 2115 | 1.290 |
Why?
|
Antibiotics, Antineoplastic | 6 | 2023 | 675 | 1.180 |
Why?
|
Immunotherapy | 14 | 2024 | 4641 | 1.170 |
Why?
|
Doxorubicin | 7 | 2024 | 2209 | 1.130 |
Why?
|
Heart Ventricles | 10 | 2021 | 3806 | 1.070 |
Why?
|
Antineoplastic Agents | 18 | 2023 | 13591 | 1.000 |
Why?
|
Hypertrophy, Left Ventricular | 7 | 2021 | 849 | 0.970 |
Why?
|
Fibrosis | 13 | 2024 | 2038 | 0.950 |
Why?
|
Gadolinium | 5 | 2020 | 959 | 0.930 |
Why?
|
Plaque, Atherosclerotic | 3 | 2021 | 1505 | 0.930 |
Why?
|
Atherosclerosis | 5 | 2023 | 3401 | 0.910 |
Why?
|
Registries | 11 | 2023 | 8176 | 0.900 |
Why?
|
Cicatrix | 3 | 2014 | 781 | 0.880 |
Why?
|
Cardiovascular Agents | 4 | 2023 | 839 | 0.870 |
Why?
|
Echocardiography | 20 | 2024 | 4962 | 0.810 |
Why?
|
Cardiac Imaging Techniques | 4 | 2021 | 267 | 0.790 |
Why?
|
Coronary Vasospasm | 1 | 2022 | 81 | 0.780 |
Why?
|
Atrial Fibrillation | 9 | 2023 | 5105 | 0.770 |
Why?
|
Contrast Media | 16 | 2020 | 5298 | 0.740 |
Why?
|
Humans | 184 | 2024 | 758381 | 0.720 |
Why?
|
Pulmonary Veins | 4 | 2014 | 745 | 0.720 |
Why?
|
Echocardiography, Doppler | 7 | 2013 | 898 | 0.710 |
Why?
|
Middle Aged | 90 | 2024 | 219560 | 0.690 |
Why?
|
Magnetic Resonance Imaging | 26 | 2021 | 36285 | 0.680 |
Why?
|
Head and Neck Neoplasms | 5 | 2023 | 2882 | 0.660 |
Why?
|
Symporters | 1 | 2022 | 360 | 0.660 |
Why?
|
Heart | 11 | 2024 | 4382 | 0.660 |
Why?
|
Myocardial Infarction | 11 | 2022 | 11424 | 0.650 |
Why?
|
Electrocardiography | 10 | 2021 | 6363 | 0.650 |
Why?
|
Cocaine-Related Disorders | 2 | 2019 | 461 | 0.650 |
Why?
|
Retrospective Studies | 41 | 2024 | 80170 | 0.650 |
Why?
|
Atrial Function, Left | 2 | 2017 | 184 | 0.650 |
Why?
|
Pericardial Effusion | 1 | 2021 | 247 | 0.650 |
Why?
|
Lymphocyte Count | 1 | 2020 | 778 | 0.620 |
Why?
|
HIV Long-Term Survivors | 1 | 2019 | 121 | 0.610 |
Why?
|
Male | 108 | 2024 | 358742 | 0.610 |
Why?
|
Patient Readmission | 5 | 2023 | 3261 | 0.600 |
Why?
|
Sleep Apnea Syndromes | 2 | 2018 | 973 | 0.600 |
Why?
|
Adrenal Cortex Hormones | 3 | 2024 | 1870 | 0.590 |
Why?
|
Female | 109 | 2024 | 390316 | 0.590 |
Why?
|
Aged | 66 | 2024 | 168217 | 0.590 |
Why?
|
Sarcomeres | 2 | 2017 | 367 | 0.580 |
Why?
|
Renin-Angiotensin System | 1 | 2022 | 733 | 0.570 |
Why?
|
Predictive Value of Tests | 20 | 2022 | 15225 | 0.570 |
Why?
|
Mitral Valve | 3 | 2018 | 1466 | 0.550 |
Why?
|
Running | 5 | 2009 | 483 | 0.540 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2024 | 12076 | 0.530 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2023 | 2004 | 0.500 |
Why?
|
Heart Conduction System | 1 | 2021 | 1011 | 0.500 |
Why?
|
Catheter Ablation | 5 | 2023 | 2740 | 0.490 |
Why?
|
Heart Rate | 7 | 2023 | 4166 | 0.480 |
Why?
|
Cardiomyopathy, Dilated | 3 | 2018 | 818 | 0.480 |
Why?
|
Cranial Irradiation | 1 | 2017 | 390 | 0.480 |
Why?
|
Protease Inhibitors | 1 | 2018 | 754 | 0.480 |
Why?
|
Lymphoma | 1 | 2023 | 1896 | 0.460 |
Why?
|
Risk Factors | 34 | 2024 | 73806 | 0.450 |
Why?
|
Cardiomyopathy, Hypertrophic | 5 | 2017 | 1309 | 0.450 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1454 | 0.450 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2019 | 1240 | 0.440 |
Why?
|
Action Potentials | 1 | 2021 | 1816 | 0.440 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1557 | 0.440 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2020 | 574 | 0.440 |
Why?
|
Carotid Arteries | 1 | 2017 | 939 | 0.430 |
Why?
|
Cardiac Volume | 1 | 2013 | 199 | 0.430 |
Why?
|
Troponin | 6 | 2023 | 500 | 0.420 |
Why?
|
Troponin T | 6 | 2022 | 761 | 0.420 |
Why?
|
Ischemic Attack, Transient | 2 | 2019 | 878 | 0.420 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 3217 | 0.420 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13245 | 0.390 |
Why?
|
Myocytes, Cardiac | 8 | 2018 | 1655 | 0.390 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2016 | 1245 | 0.380 |
Why?
|
Influenza Vaccines | 1 | 2019 | 759 | 0.380 |
Why?
|
Influenza, Human | 2 | 2021 | 1516 | 0.380 |
Why?
|
Papillomaviridae | 1 | 2017 | 1121 | 0.380 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 872 | 0.370 |
Why?
|
Incidence | 11 | 2022 | 21273 | 0.370 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2019 | 1895 | 0.360 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2006 | 615 | 0.360 |
Why?
|
Physical Endurance | 3 | 2009 | 362 | 0.360 |
Why?
|
Pneumonia, Viral | 4 | 2021 | 3196 | 0.360 |
Why?
|
Prognosis | 16 | 2023 | 29558 | 0.350 |
Why?
|
Cyclooxygenase 2 | 3 | 2008 | 597 | 0.350 |
Why?
|
Gadolinium DTPA | 7 | 2018 | 823 | 0.340 |
Why?
|
Iloprost | 2 | 2006 | 25 | 0.340 |
Why?
|
Sleep Apnea, Obstructive | 4 | 2020 | 1852 | 0.340 |
Why?
|
Nitric Oxide Synthase Type II | 3 | 2007 | 506 | 0.340 |
Why?
|
Disease Progression | 11 | 2021 | 13468 | 0.330 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2540 | 0.330 |
Why?
|
Hematology | 1 | 2022 | 241 | 0.320 |
Why?
|
Disease-Free Survival | 5 | 2020 | 6821 | 0.310 |
Why?
|
Mitral Valve Insufficiency | 5 | 2023 | 1401 | 0.310 |
Why?
|
Hypertension | 6 | 2022 | 8503 | 0.310 |
Why?
|
Breast Neoplasms | 8 | 2024 | 21017 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3076 | 0.310 |
Why?
|
Aging | 2 | 2020 | 8651 | 0.300 |
Why?
|
Neutrophils | 1 | 2020 | 3765 | 0.300 |
Why?
|
Physical Fitness | 2 | 2016 | 732 | 0.300 |
Why?
|
Risk Assessment | 14 | 2024 | 23883 | 0.290 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2057 | 0.290 |
Why?
|
Exercise Test | 8 | 2024 | 2121 | 0.290 |
Why?
|
Adult | 48 | 2024 | 219916 | 0.290 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 2416 | 0.280 |
Why?
|
Aged, 80 and over | 18 | 2022 | 58681 | 0.280 |
Why?
|
Time Factors | 13 | 2021 | 39873 | 0.280 |
Why?
|
Anti-Retroviral Agents | 4 | 2020 | 1780 | 0.280 |
Why?
|
Case-Control Studies | 12 | 2023 | 22031 | 0.270 |
Why?
|
Radiation Oncology | 1 | 2022 | 563 | 0.270 |
Why?
|
Coronary Artery Disease | 8 | 2019 | 6363 | 0.270 |
Why?
|
Follow-Up Studies | 14 | 2023 | 39060 | 0.260 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2006 | 107 | 0.260 |
Why?
|
Microcirculation | 1 | 2010 | 1273 | 0.260 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1612 | 0.250 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3480 | 0.250 |
Why?
|
Adenocarcinoma | 3 | 2024 | 6313 | 0.250 |
Why?
|
Coronary Angiography | 7 | 2018 | 4451 | 0.250 |
Why?
|
Body Size | 1 | 2008 | 462 | 0.250 |
Why?
|
Ventricular Function, Right | 3 | 2020 | 609 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4023 | 0.240 |
Why?
|
Ventricular Function | 1 | 2006 | 406 | 0.240 |
Why?
|
Physical Exertion | 2 | 2006 | 662 | 0.240 |
Why?
|
Heart Neoplasms | 3 | 2016 | 360 | 0.220 |
Why?
|
CD4 Lymphocyte Count | 2 | 2020 | 2569 | 0.220 |
Why?
|
Medical Oncology | 7 | 2024 | 2312 | 0.220 |
Why?
|
Triglycerides | 3 | 2020 | 2450 | 0.220 |
Why?
|
Anthropometry | 1 | 2008 | 1347 | 0.220 |
Why?
|
Cardiomegaly | 2 | 2016 | 591 | 0.210 |
Why?
|
Prospective Studies | 14 | 2024 | 54136 | 0.200 |
Why?
|
Triage | 2 | 2021 | 986 | 0.200 |
Why?
|
Stroke | 4 | 2019 | 9696 | 0.200 |
Why?
|
Nitrates | 2 | 2022 | 263 | 0.200 |
Why?
|
Carbolines | 1 | 2024 | 286 | 0.200 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3227 | 0.200 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2020 | 3758 | 0.190 |
Why?
|
Natriuretic Peptide, Brain | 4 | 2024 | 1704 | 0.190 |
Why?
|
Echocardiography, Transesophageal | 8 | 2007 | 1088 | 0.190 |
Why?
|
Thyroiditis | 1 | 2021 | 86 | 0.190 |
Why?
|
Smoking | 1 | 2018 | 9042 | 0.190 |
Why?
|
Vincristine | 1 | 2024 | 1038 | 0.190 |
Why?
|
Sympathetic Nervous System | 1 | 2024 | 518 | 0.190 |
Why?
|
Extracellular Space | 2 | 2013 | 564 | 0.190 |
Why?
|
Mitral Valve Prolapse | 1 | 2023 | 214 | 0.190 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 402 | 0.190 |
Why?
|
Lung | 3 | 2019 | 9985 | 0.190 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3425 | 0.190 |
Why?
|
Cardiology | 3 | 2024 | 1667 | 0.180 |
Why?
|
Myocardial Reperfusion Injury | 3 | 2010 | 478 | 0.180 |
Why?
|
Fatal Outcome | 4 | 2019 | 1829 | 0.180 |
Why?
|
Ventricular Dysfunction | 1 | 2021 | 144 | 0.180 |
Why?
|
Giant Cells | 1 | 2021 | 185 | 0.180 |
Why?
|
Asymptomatic Diseases | 3 | 2018 | 584 | 0.180 |
Why?
|
Friedreich Ataxia | 1 | 2021 | 77 | 0.180 |
Why?
|
Sports | 1 | 2006 | 699 | 0.180 |
Why?
|
Immunologic Factors | 2 | 2020 | 1585 | 0.180 |
Why?
|
Thorax | 1 | 2023 | 553 | 0.170 |
Why?
|
Observer Variation | 4 | 2013 | 2600 | 0.170 |
Why?
|
Cause of Death | 3 | 2020 | 3674 | 0.170 |
Why?
|
Diagnosis, Differential | 11 | 2021 | 12951 | 0.170 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 2239 | 0.170 |
Why?
|
Biology | 1 | 2021 | 289 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 11 | 2019 | 20500 | 0.170 |
Why?
|
Treatment Outcome | 15 | 2024 | 64379 | 0.170 |
Why?
|
Myasthenia Gravis | 1 | 2022 | 212 | 0.170 |
Why?
|
Reference Values | 4 | 2013 | 4919 | 0.170 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7377 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6493 | 0.170 |
Why?
|
Arrhythmias, Cardiac | 3 | 2023 | 2248 | 0.170 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2021 | 123 | 0.160 |
Why?
|
Viral Load | 2 | 2019 | 3321 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 226 | 0.160 |
Why?
|
Prednisone | 1 | 2024 | 1565 | 0.160 |
Why?
|
Heart Failure, Diastolic | 1 | 2019 | 76 | 0.160 |
Why?
|
Denmark | 1 | 2021 | 759 | 0.160 |
Why?
|
Ischemic Preconditioning, Myocardial | 2 | 2009 | 69 | 0.160 |
Why?
|
Calcium Channel Blockers | 1 | 2022 | 694 | 0.160 |
Why?
|
Survival Rate | 4 | 2024 | 12721 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2021 | 12096 | 0.150 |
Why?
|
Amygdala | 2 | 2023 | 1351 | 0.150 |
Why?
|
Proportional Hazards Models | 6 | 2019 | 12440 | 0.150 |
Why?
|
Cyclophosphamide | 1 | 2024 | 2218 | 0.150 |
Why?
|
Coronary Vessels | 2 | 2021 | 3072 | 0.150 |
Why?
|
Peptide Fragments | 4 | 2024 | 5098 | 0.150 |
Why?
|
Monocytes | 3 | 2022 | 2570 | 0.150 |
Why?
|
Sex Factors | 5 | 2021 | 10505 | 0.150 |
Why?
|
Obesity | 3 | 2016 | 12870 | 0.150 |
Why?
|
Mice, Inbred C57BL | 9 | 2016 | 22006 | 0.150 |
Why?
|
Hospitalization | 5 | 2021 | 10653 | 0.150 |
Why?
|
Body Mass Index | 6 | 2020 | 12876 | 0.140 |
Why?
|
Edema | 1 | 2021 | 768 | 0.140 |
Why?
|
Edema, Cardiac | 1 | 2016 | 19 | 0.140 |
Why?
|
Adipose Tissue | 2 | 2020 | 3299 | 0.140 |
Why?
|
Fluorouracil | 1 | 2022 | 1631 | 0.140 |
Why?
|
Radiopharmaceuticals | 2 | 2024 | 2634 | 0.140 |
Why?
|
Melanoma | 4 | 2020 | 5691 | 0.140 |
Why?
|
Adaptive Immunity | 1 | 2022 | 726 | 0.140 |
Why?
|
Young Adult | 14 | 2021 | 58808 | 0.140 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 353 | 0.140 |
Why?
|
Sodium | 1 | 2022 | 1588 | 0.140 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 792 | 0.140 |
Why?
|
Methylprednisolone | 1 | 2018 | 384 | 0.140 |
Why?
|
Athletic Injuries | 1 | 2006 | 1211 | 0.130 |
Why?
|
Confusion | 1 | 2018 | 279 | 0.130 |
Why?
|
Immune System | 1 | 2021 | 796 | 0.130 |
Why?
|
Anticholesteremic Agents | 1 | 2023 | 963 | 0.130 |
Why?
|
Vasodilator Agents | 2 | 2014 | 973 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2023 | 8530 | 0.130 |
Why?
|
Thrombophilia | 1 | 2018 | 304 | 0.130 |
Why?
|
Radiotherapy | 2 | 2020 | 1504 | 0.130 |
Why?
|
Mortality | 2 | 2018 | 2885 | 0.130 |
Why?
|
Hormones | 1 | 2019 | 869 | 0.130 |
Why?
|
Coronary Circulation | 1 | 2021 | 1561 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2007 | 703 | 0.130 |
Why?
|
Glutamine | 2 | 2009 | 575 | 0.130 |
Why?
|
Mutation | 2 | 2017 | 29915 | 0.130 |
Why?
|
NG-Nitroarginine Methyl Ester | 3 | 2014 | 260 | 0.130 |
Why?
|
Radiography, Thoracic | 2 | 2019 | 1296 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 1016 | 0.120 |
Why?
|
Extracellular Matrix | 2 | 2013 | 1723 | 0.120 |
Why?
|
Coronary Care Units | 1 | 2016 | 235 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1503 | 0.120 |
Why?
|
Aorta | 5 | 2020 | 2037 | 0.120 |
Why?
|
Double-Blind Method | 3 | 2024 | 12262 | 0.120 |
Why?
|
Boston | 3 | 2020 | 9304 | 0.120 |
Why?
|
Animals | 19 | 2024 | 167777 | 0.120 |
Why?
|
Cohort Studies | 10 | 2024 | 41252 | 0.120 |
Why?
|
Acute Coronary Syndrome | 2 | 2018 | 2180 | 0.120 |
Why?
|
Papillary Muscles | 2 | 2023 | 192 | 0.120 |
Why?
|
Chest Pain | 2 | 2019 | 1090 | 0.120 |
Why?
|
Fistula | 2 | 2006 | 214 | 0.120 |
Why?
|
United States | 9 | 2023 | 72140 | 0.120 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1402 | 0.110 |
Why?
|
Aneurysm, False | 2 | 2007 | 254 | 0.110 |
Why?
|
Immunosuppressive Agents | 2 | 2024 | 4158 | 0.110 |
Why?
|
Pyrimidinones | 1 | 2016 | 383 | 0.110 |
Why?
|
Endocarditis, Bacterial | 3 | 2006 | 442 | 0.110 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10171 | 0.110 |
Why?
|
Piperazines | 1 | 2024 | 2511 | 0.110 |
Why?
|
Pericardium | 1 | 2018 | 674 | 0.110 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2014 | 163 | 0.110 |
Why?
|
Recurrence | 3 | 2014 | 8426 | 0.110 |
Why?
|
Respiratory Insufficiency | 3 | 2021 | 1230 | 0.110 |
Why?
|
Laryngeal Neoplasms | 1 | 2016 | 514 | 0.110 |
Why?
|
ROC Curve | 1 | 2020 | 3563 | 0.100 |
Why?
|
Kidney Failure, Chronic | 2 | 2020 | 2457 | 0.100 |
Why?
|
Defibrillators, Implantable | 2 | 2021 | 1487 | 0.100 |
Why?
|
Age Factors | 5 | 2021 | 18357 | 0.100 |
Why?
|
Databases, Factual | 2 | 2018 | 7980 | 0.100 |
Why?
|
Shock, Cardiogenic | 2 | 2016 | 707 | 0.100 |
Why?
|
Consensus | 2 | 2021 | 3099 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4839 | 0.100 |
Why?
|
Prevalence | 4 | 2018 | 15646 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2018 | 0.100 |
Why?
|
Ischemia | 1 | 2021 | 1863 | 0.100 |
Why?
|
Brain | 2 | 2018 | 26951 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1160 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2860 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4106 | 0.100 |
Why?
|
Body Height | 2 | 2008 | 1567 | 0.100 |
Why?
|
Blood Pressure | 6 | 2020 | 8453 | 0.100 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2751 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1890 | 0.090 |
Why?
|
Cross Infection | 1 | 2020 | 1432 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2019 | 1956 | 0.090 |
Why?
|
Pyridones | 1 | 2016 | 785 | 0.090 |
Why?
|
Fever | 1 | 2018 | 1617 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2020 | 1786 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1647 | 0.090 |
Why?
|
Spironolactone | 1 | 2014 | 410 | 0.090 |
Why?
|
Mice | 13 | 2023 | 81107 | 0.090 |
Why?
|
Apoptosis | 4 | 2007 | 9468 | 0.090 |
Why?
|
Myoglobin | 2 | 2009 | 159 | 0.090 |
Why?
|
Decision Support Systems, Clinical | 1 | 2019 | 1162 | 0.090 |
Why?
|
Myocardial Contraction | 4 | 2008 | 1516 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4336 | 0.090 |
Why?
|
Adaptation, Physiological | 2 | 2007 | 1295 | 0.090 |
Why?
|
Exercise | 1 | 2006 | 5788 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20052 | 0.090 |
Why?
|
Drug Interactions | 2 | 2022 | 1414 | 0.080 |
Why?
|
Shock, Septic | 3 | 2021 | 761 | 0.080 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2008 | 352 | 0.080 |
Why?
|
Comorbidity | 3 | 2021 | 10495 | 0.080 |
Why?
|
Nitric Oxide | 3 | 2007 | 2131 | 0.080 |
Why?
|
Cardiovascular System | 1 | 2016 | 835 | 0.080 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 6457 | 0.080 |
Why?
|
Adolescent | 11 | 2023 | 87888 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2016 | 18125 | 0.080 |
Why?
|
Pandemics | 4 | 2022 | 8611 | 0.080 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11152 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2144 | 0.080 |
Why?
|
Heart Valve Diseases | 2 | 2006 | 1033 | 0.080 |
Why?
|
Aldosterone | 1 | 2013 | 866 | 0.080 |
Why?
|
Hospital Mortality | 2 | 2021 | 5273 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10747 | 0.080 |
Why?
|
Pyrazoles | 1 | 2018 | 1990 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3485 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2016 | 1297 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1855 | 0.070 |
Why?
|
Skating | 1 | 2007 | 20 | 0.070 |
Why?
|
Body Surface Area | 1 | 2008 | 197 | 0.070 |
Why?
|
Cor Triatriatum | 1 | 2007 | 14 | 0.070 |
Why?
|
Capillaries | 1 | 2010 | 744 | 0.070 |
Why?
|
Body Weight | 2 | 2008 | 4603 | 0.070 |
Why?
|
Dobutamine | 1 | 2007 | 116 | 0.070 |
Why?
|
Weight Loss | 1 | 2018 | 2671 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3526 | 0.070 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 2006 | 48 | 0.070 |
Why?
|
Cardiotonic Agents | 2 | 2007 | 539 | 0.070 |
Why?
|
Heart Transplantation | 2 | 2021 | 3220 | 0.070 |
Why?
|
Myxoma | 1 | 2007 | 114 | 0.070 |
Why?
|
Aortic Valve | 2 | 2007 | 1950 | 0.070 |
Why?
|
Ships | 1 | 2006 | 53 | 0.070 |
Why?
|
Random Allocation | 2 | 2013 | 2385 | 0.070 |
Why?
|
Viridans Streptococci | 1 | 2006 | 16 | 0.070 |
Why?
|
Vaccination | 1 | 2019 | 3356 | 0.070 |
Why?
|
Echocardiography, Stress | 1 | 2007 | 134 | 0.070 |
Why?
|
Pilot Projects | 3 | 2016 | 8554 | 0.070 |
Why?
|
Myocardial Ischemia | 2 | 2014 | 2108 | 0.070 |
Why?
|
Myocardial Stunning | 1 | 2006 | 66 | 0.070 |
Why?
|
Creatine Kinase, MB Form | 1 | 2006 | 202 | 0.070 |
Why?
|
Body Constitution | 1 | 2006 | 273 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11709 | 0.070 |
Why?
|
Superoxides | 1 | 2007 | 386 | 0.070 |
Why?
|
Pyrimidines | 1 | 2018 | 3006 | 0.070 |
Why?
|
Sclerosing Solutions | 1 | 2006 | 79 | 0.070 |
Why?
|
Europe | 2 | 2024 | 3420 | 0.070 |
Why?
|
Vascular Fistula | 1 | 2006 | 50 | 0.070 |
Why?
|
Balloon Occlusion | 1 | 2007 | 125 | 0.070 |
Why?
|
Heart Murmurs | 1 | 2006 | 93 | 0.060 |
Why?
|
Aortic Valve Insufficiency | 2 | 2007 | 578 | 0.060 |
Why?
|
Luminescent Measurements | 1 | 2007 | 341 | 0.060 |
Why?
|
Algorithms | 3 | 2021 | 13959 | 0.060 |
Why?
|
Probability | 2 | 2008 | 2467 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 25953 | 0.060 |
Why?
|
Intracranial Embolism | 1 | 2007 | 189 | 0.060 |
Why?
|
Solvents | 1 | 2006 | 292 | 0.060 |
Why?
|
Paraganglioma | 1 | 2006 | 142 | 0.060 |
Why?
|
bcl-X Protein | 1 | 2006 | 411 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1003 | 0.060 |
Why?
|
Phenotype | 3 | 2017 | 16534 | 0.060 |
Why?
|
Survivors | 1 | 2015 | 2371 | 0.060 |
Why?
|
Diastole | 1 | 2006 | 781 | 0.060 |
Why?
|
Embolism | 1 | 2007 | 401 | 0.060 |
Why?
|
Radionuclide Imaging | 2 | 2024 | 1975 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6852 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2017 | 3047 | 0.060 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2006 | 141 | 0.060 |
Why?
|
Atrial Appendage | 1 | 2007 | 282 | 0.060 |
Why?
|
Systole | 1 | 2006 | 936 | 0.060 |
Why?
|
3-Iodobenzylguanidine | 1 | 2024 | 114 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2010 | 1431 | 0.060 |
Why?
|
Peroxidase | 1 | 2006 | 605 | 0.060 |
Why?
|
Prolapse | 1 | 2023 | 63 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2008 | 14354 | 0.050 |
Why?
|
Hemodynamics | 3 | 2013 | 4159 | 0.050 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2023 | 89 | 0.050 |
Why?
|
Biopsy | 3 | 2021 | 6768 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4504 | 0.050 |
Why?
|
Arteriovenous Malformations | 1 | 2006 | 397 | 0.050 |
Why?
|
Reactive Oxygen Species | 2 | 2007 | 2129 | 0.050 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2023 | 213 | 0.050 |
Why?
|
Neoplasm Transplantation | 1 | 2006 | 2013 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2006 | 1370 | 0.050 |
Why?
|
Receptor, erbB-2 | 2 | 2024 | 2553 | 0.050 |
Why?
|
Ultrasonography | 3 | 2016 | 5952 | 0.050 |
Why?
|
Streptococcal Infections | 1 | 2006 | 617 | 0.050 |
Why?
|
Benzazepines | 1 | 2023 | 310 | 0.050 |
Why?
|
Lipopolysaccharides | 1 | 2009 | 2204 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1171 | 0.050 |
Why?
|
Odds Ratio | 1 | 2013 | 9650 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2006 | 648 | 0.050 |
Why?
|
Societies, Medical | 2 | 2024 | 3891 | 0.050 |
Why?
|
Osteopontin | 1 | 2022 | 301 | 0.050 |
Why?
|
Superinfection | 1 | 2021 | 64 | 0.050 |
Why?
|
Ritonavir | 1 | 2022 | 328 | 0.050 |
Why?
|
Diplopia | 1 | 2022 | 215 | 0.050 |
Why?
|
Proteinuria | 1 | 2023 | 594 | 0.040 |
Why?
|
Thrombosis | 2 | 2021 | 2929 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2007 | 9518 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 139 | 0.040 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2007 | 938 | 0.040 |
Why?
|
Severity of Illness Index | 5 | 2012 | 15785 | 0.040 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2007 | 695 | 0.040 |
Why?
|
Massachusetts | 3 | 2021 | 8823 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 125 | 0.040 |
Why?
|
Polysomnography | 2 | 2020 | 1825 | 0.040 |
Why?
|
Endocardium | 1 | 2021 | 246 | 0.040 |
Why?
|
Ethanol | 1 | 2006 | 1325 | 0.040 |
Why?
|
Chronic Disease | 3 | 2014 | 9266 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2022 | 655 | 0.040 |
Why?
|
Quebec | 1 | 2019 | 140 | 0.040 |
Why?
|
Adrenal Gland Diseases | 1 | 2020 | 141 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2023 | 776 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2024 | 830 | 0.040 |
Why?
|
HSP72 Heat-Shock Proteins | 2 | 2009 | 40 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4567 | 0.040 |
Why?
|
Urogenital Neoplasms | 1 | 2020 | 135 | 0.040 |
Why?
|
American Heart Association | 1 | 2023 | 1039 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 3734 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 926 | 0.040 |
Why?
|
Cell Division | 1 | 2006 | 4459 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2008 | 1292 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7810 | 0.040 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2006 | 1547 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 17768 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2006 | 6127 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1705 | 0.040 |
Why?
|
Meglumine | 1 | 2018 | 145 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 782 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 488 | 0.040 |
Why?
|
Swine | 1 | 2008 | 5892 | 0.040 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2024 | 1153 | 0.040 |
Why?
|
Echocardiography, Doppler, Pulsed | 2 | 2007 | 69 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2023 | 3812 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 545 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2006 | 1916 | 0.040 |
Why?
|
Myositis | 1 | 2020 | 269 | 0.040 |
Why?
|
Hypertension, Pulmonary | 1 | 2008 | 1565 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2020 | 3586 | 0.040 |
Why?
|
Protons | 1 | 2022 | 1112 | 0.040 |
Why?
|
Thoracic Neoplasms | 1 | 2019 | 266 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2021 | 604 | 0.030 |
Why?
|
Troponin I | 1 | 2021 | 632 | 0.030 |
Why?
|
Dyspnea | 2 | 2019 | 1344 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2007 | 3100 | 0.030 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2020 | 321 | 0.030 |
Why?
|
Sarcoma | 1 | 2007 | 1785 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2021 | 771 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2024 | 2211 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2019 | 488 | 0.030 |
Why?
|
Extremities | 1 | 2021 | 865 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2020 | 665 | 0.030 |
Why?
|
Injections, Intravenous | 2 | 2008 | 1378 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2018 | 648 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2017 | 819 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2640 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1386 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2532 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1627 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3208 | 0.030 |
Why?
|
Adenine | 1 | 2018 | 975 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2154 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2896 | 0.030 |
Why?
|
Body Water | 1 | 2013 | 341 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2013 | 6233 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 2018 | 935 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3132 | 0.020 |
Why?
|
Hypertrophy | 1 | 2013 | 555 | 0.020 |
Why?
|
Cell Size | 1 | 2013 | 623 | 0.020 |
Why?
|
Androgen Antagonists | 1 | 2020 | 1442 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2006 | 3603 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 12760 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1788 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3069 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8946 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 2021 | 1279 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2504 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1639 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4549 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2618 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2551 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2215 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11894 | 0.020 |
Why?
|
Quercetin | 1 | 2009 | 96 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2021 | 3056 | 0.020 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 2008 | 80 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2796 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2129 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2416 | 0.020 |
Why?
|
Malondialdehyde | 1 | 2008 | 111 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2016 | 14481 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 2007 | 123 | 0.020 |
Why?
|
Organ Size | 1 | 2012 | 2252 | 0.020 |
Why?
|
Mesenteric Artery, Superior | 1 | 2007 | 95 | 0.020 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2007 | 91 | 0.020 |
Why?
|
Heart Valve Prosthesis | 2 | 2006 | 1466 | 0.020 |
Why?
|
Physical Education and Training | 1 | 2007 | 100 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2008 | 622 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2850 | 0.020 |
Why?
|
Creatine Kinase | 1 | 2009 | 686 | 0.020 |
Why?
|
Acute Disease | 1 | 2017 | 7225 | 0.020 |
Why?
|
Xanthine Oxidase | 1 | 2006 | 69 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2244 | 0.020 |
Why?
|
Sepsis | 1 | 2021 | 2587 | 0.020 |
Why?
|
Embolectomy | 1 | 2007 | 129 | 0.020 |
Why?
|
Sarcoplasmic Reticulum | 1 | 2006 | 163 | 0.020 |
Why?
|
Paresis | 1 | 2007 | 176 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7016 | 0.020 |
Why?
|
Aortography | 1 | 2007 | 420 | 0.020 |
Why?
|
Infant | 1 | 2008 | 36054 | 0.020 |
Why?
|
Graft Survival | 1 | 2016 | 3794 | 0.020 |
Why?
|
Endotoxemia | 1 | 2006 | 196 | 0.020 |
Why?
|
Allopurinol | 1 | 2006 | 198 | 0.020 |
Why?
|
Heart Septum | 1 | 2006 | 303 | 0.020 |
Why?
|
Child, Preschool | 1 | 2008 | 42058 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9273 | 0.020 |
Why?
|
Collagen | 1 | 2013 | 2635 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1878 | 0.010 |
Why?
|
Syncope | 1 | 2007 | 427 | 0.010 |
Why?
|
Bundle-Branch Block | 1 | 2006 | 278 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10146 | 0.010 |
Why?
|
Endotoxins | 1 | 2006 | 521 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5629 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2007 | 1570 | 0.010 |
Why?
|
Pulmonary Edema | 1 | 2006 | 408 | 0.010 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2006 | 237 | 0.010 |
Why?
|
Nausea | 1 | 2006 | 677 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5199 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2006 | 343 | 0.010 |
Why?
|
Endosonography | 1 | 2007 | 607 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4426 | 0.010 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2006 | 632 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2007 | 875 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2006 | 1153 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5818 | 0.010 |
Why?
|
HIV-1 | 1 | 2019 | 6850 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14641 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2006 | 1066 | 0.010 |
Why?
|
Incidental Findings | 1 | 2007 | 694 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1630 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4771 | 0.010 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2006 | 353 | 0.010 |
Why?
|
Creatinine | 1 | 2007 | 1892 | 0.010 |
Why?
|
Antioxidants | 1 | 2009 | 1662 | 0.010 |
Why?
|
Oxygen | 1 | 2012 | 4192 | 0.010 |
Why?
|
Aortic Valve Stenosis | 1 | 2013 | 2002 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5797 | 0.010 |
Why?
|
Pacemaker, Artificial | 1 | 2006 | 808 | 0.010 |
Why?
|
Hypotension | 1 | 2006 | 879 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2007 | 1419 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 2006 | 486 | 0.010 |
Why?
|
Canada | 1 | 2006 | 2111 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2006 | 939 | 0.010 |
Why?
|
Thromboembolism | 1 | 2006 | 996 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10719 | 0.010 |
Why?
|
Child | 1 | 2008 | 79813 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13276 | 0.010 |
Why?
|
Preoperative Care | 1 | 2006 | 2249 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2006 | 1406 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1422 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 6955 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3709 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8297 | 0.010 |
Why?
|
Image Enhancement | 1 | 2006 | 2880 | 0.010 |
Why?
|
Calcium | 1 | 2006 | 5721 | 0.010 |
Why?
|
Survival Analysis | 1 | 2006 | 10112 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2007 | 18942 | 0.010 |
Why?
|
Research Design | 1 | 2006 | 6154 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2007 | 8981 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2006 | 15638 | 0.000 |
Why?
|